Skip to main content

Yeaman Kevin J's Form 4 filing

Dolby Laboratories, Inc. (DLB) · filed Dec 16, 2021

Accession no.
0001209191-21-070106
Filed
Dec 16, 2021
Trade date
Dec 15-16, 2021
Filing delay
1 day
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 8 non-derivative transactions and 3 derivative transactions. Open-market sales total $3.19M. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Yeaman Kevin JCIK 0001200469Director, Officer (President and CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 15, 2021Class A Common StockFTax withholdingDisposed−10,882$90.55−$985,365.184,467Direct
Dec 15, 2021Class A Common StockAGrant or awardAcquired+43,987$0.00$0128,454Direct
Dec 15, 2021Class A Common StockMOption exerciseAcquired+29,457$42.98+$1,266,061.8656,870Indirect
Dec 15, 2021Class A Common StockSSaleDisposed−21,361$90.47F5−$1,932,529.6735,509Indirect
Dec 15, 2021Class A Common StockSSaleDisposed−8,096$91.17F6−$738,112.3227,413Indirect
Dec 16, 2021Class A Common StockSSaleDisposed−4,723$91.04F7−$429,981.9222,690Indirect
Dec 16, 2021Class A Common StockSSaleDisposed−949$91.96F8−$87,270.0421,741Indirect
Dec 16, 2021Class A Common StockFTax withholdingDisposed−5,268$91.80−$483,602.4117,829Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Dec 15, 2021Class A Common StockAGrant or awardAcquired+21,993$0.00$021,993Direct
Dec 15, 2021Class A Common StockAGrant or awardAcquired+91,047$0.00$091,047Direct
Dec 15, 2021Class A Common StockMOption exerciseDisposed−29,457$0.00$0217,957Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F5

This transaction was executed in multiple trades at prices ranging from $90.03 to $90.98, inclusive. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

Referenced by the price of 1 transaction in Table I.

F6

This transaction was executed in multiple trades at prices ranging from $91.00 to $91.38, inclusive. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

Referenced by the price of 1 transaction in Table I.

F7

This transaction was executed in multiple trades at prices ranging from $90.65 to $91.45, inclusive. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

Referenced by the price of 1 transaction in Table I.

F8

This transaction was executed in multiple trades at prices ranging from $91.81 to $92.15, inclusive. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

Referenced by the price of 1 transaction in Table I.

Remarks

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

Read the full filing on SEC EDGAR (opens in a new tab)